Global Cell Expansion Technologies 麻豆原创 Research Report 2023

Publication ID:

PB503235652

Publication Date:

March 15, 2023

Pages:

110

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global Cell Expansion Technologies market was valued at US$ 18060 million in 2022 and is anticipated to reach US$ 32170 million by 2029, witnessing a CAGR of 10.1% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Depending upon the type of cell, the global cell expansion market can be broadly split into human cells and animal cells. The human cell can be further divided into stem cells and differentiated cells. Revenue-wise, the human stem cell segment accounts for a dominant share in the market on account of the rising prevalence of various chronic diseases and support provided by the government. In 2016, it held a substantial 58.1% share in the overall revenue in the global cell expansion market.

Geographically, the key segments of the market are Asia Pacific, Europe, North America, Latin America, and the Middle East and Africa. Among them, North America is the leading market on account of the concentration of many key players in the region and the increasing research and development in the field. Going forward, North America is slated to slightly pare its market share to hold a 37.7% share in it by 2024. It will still, however, remain the dominant market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cell Expansion Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Expansion Technologies.
The Cell Expansion Technologies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cell Expansion Technologies market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Expansion Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Becton
Dickinson
GE Healthcare
Thermo Fisher Scientific Inc.
Corning Inc
Danaher Corp
Merck Millipore
Terumo BCT
STEMCELL Technologies
Sigma-Aldrich Corp
Miltenyi Biotec
Life Technologies
Replicell
Neximmune
TC Biopharm
Pluristem Therapeutics
ReNeuron
Voria Biomaterials
CellProthera
Cytomatrix
Segment by Type
Reagents
Media
Sera
Disposables
Segment by Application
Clinical diagnostics
Drug discovery and development
Regenerative medicine
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Expansion Technologies companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Cell Expansion Technologies 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Reagents
1.2.3 Media
1.2.4 Sera
1.2.5 Disposables
1.3 麻豆原创 by Application
1.3.1 Global Cell Expansion Technologies 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clinical diagnostics
1.3.3 Drug discovery and development
1.3.4 Regenerative medicine
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Expansion Technologies 麻豆原创 Perspective (2018-2029)
2.2 Cell Expansion Technologies Growth Trends by Region
2.2.1 Global Cell Expansion Technologies 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell Expansion Technologies Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Cell Expansion Technologies Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Cell Expansion Technologies 麻豆原创 Dynamics
2.3.1 Cell Expansion Technologies Industry Trends
2.3.2 Cell Expansion Technologies 麻豆原创 Drivers
2.3.3 Cell Expansion Technologies 麻豆原创 Challenges
2.3.4 Cell Expansion Technologies 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Expansion Technologies Players by Revenue
3.1.1 Global Top Cell Expansion Technologies Players by Revenue (2018-2023)
3.1.2 Global Cell Expansion Technologies Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Cell Expansion Technologies 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Expansion Technologies Revenue
3.4 Global Cell Expansion Technologies 麻豆原创 Concentration Ratio
3.4.1 Global Cell Expansion Technologies 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Expansion Technologies Revenue in 2022
3.5 Cell Expansion Technologies Key Players Head office and Area Served
3.6 Key Players Cell Expansion Technologies Product Solution and Service
3.7 Date of Enter into Cell Expansion Technologies 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Expansion Technologies Breakdown Data by Type
4.1 Global Cell Expansion Technologies Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Cell Expansion Technologies Forecasted 麻豆原创 Size by Type (2024-2029)
5 Cell Expansion Technologies Breakdown Data by Application
5.1 Global Cell Expansion Technologies Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Cell Expansion Technologies Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Cell Expansion Technologies 麻豆原创 Size (2018-2029)
6.2 North America Cell Expansion Technologies 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cell Expansion Technologies 麻豆原创 Size by Country (2018-2023)
6.4 North America Cell Expansion Technologies 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Expansion Technologies 麻豆原创 Size (2018-2029)
7.2 Europe Cell Expansion Technologies 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cell Expansion Technologies 麻豆原创 Size by Country (2018-2023)
7.4 Europe Cell Expansion Technologies 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Expansion Technologies 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Cell Expansion Technologies 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cell Expansion Technologies 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Cell Expansion Technologies 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Expansion Technologies 麻豆原创 Size (2018-2029)
9.2 Latin America Cell Expansion Technologies 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cell Expansion Technologies 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Cell Expansion Technologies 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Expansion Technologies 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Cell Expansion Technologies 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cell Expansion Technologies 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Cell Expansion Technologies 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Becton
11.1.1 Becton Company Detail
11.1.2 Becton Business Overview
11.1.3 Becton Cell Expansion Technologies Introduction
11.1.4 Becton Revenue in Cell Expansion Technologies Business (2018-2023)
11.1.5 Becton Recent Development
11.2 Dickinson
11.2.1 Dickinson Company Detail
11.2.2 Dickinson Business Overview
11.2.3 Dickinson Cell Expansion Technologies Introduction
11.2.4 Dickinson Revenue in Cell Expansion Technologies Business (2018-2023)
11.2.5 Dickinson Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Detail
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Cell Expansion Technologies Introduction
11.3.4 GE Healthcare Revenue in Cell Expansion Technologies Business (2018-2023)
11.3.5 GE Healthcare Recent Development
11.4 Thermo Fisher Scientific Inc.
11.4.1 Thermo Fisher Scientific Inc. Company Detail
11.4.2 Thermo Fisher Scientific Inc. Business Overview
11.4.3 Thermo Fisher Scientific Inc. Cell Expansion Technologies Introduction
11.4.4 Thermo Fisher Scientific Inc. Revenue in Cell Expansion Technologies Business (2018-2023)
11.4.5 Thermo Fisher Scientific Inc. Recent Development
11.5 Corning Inc
11.5.1 Corning Inc Company Detail
11.5.2 Corning Inc Business Overview
11.5.3 Corning Inc Cell Expansion Technologies Introduction
11.5.4 Corning Inc Revenue in Cell Expansion Technologies Business (2018-2023)
11.5.5 Corning Inc Recent Development
11.6 Danaher Corp
11.6.1 Danaher Corp Company Detail
11.6.2 Danaher Corp Business Overview
11.6.3 Danaher Corp Cell Expansion Technologies Introduction
11.6.4 Danaher Corp Revenue in Cell Expansion Technologies Business (2018-2023)
11.6.5 Danaher Corp Recent Development
11.7 Merck Millipore
11.7.1 Merck Millipore Company Detail
11.7.2 Merck Millipore Business Overview
11.7.3 Merck Millipore Cell Expansion Technologies Introduction
11.7.4 Merck Millipore Revenue in Cell Expansion Technologies Business (2018-2023)
11.7.5 Merck Millipore Recent Development
11.8 Terumo BCT
11.8.1 Terumo BCT Company Detail
11.8.2 Terumo BCT Business Overview
11.8.3 Terumo BCT Cell Expansion Technologies Introduction
11.8.4 Terumo BCT Revenue in Cell Expansion Technologies Business (2018-2023)
11.8.5 Terumo BCT Recent Development
11.9 STEMCELL Technologies
11.9.1 STEMCELL Technologies Company Detail
11.9.2 STEMCELL Technologies Business Overview
11.9.3 STEMCELL Technologies Cell Expansion Technologies Introduction
11.9.4 STEMCELL Technologies Revenue in Cell Expansion Technologies Business (2018-2023)
11.9.5 STEMCELL Technologies Recent Development
11.10 Sigma-Aldrich Corp
11.10.1 Sigma-Aldrich Corp Company Detail
11.10.2 Sigma-Aldrich Corp Business Overview
11.10.3 Sigma-Aldrich Corp Cell Expansion Technologies Introduction
11.10.4 Sigma-Aldrich Corp Revenue in Cell Expansion Technologies Business (2018-2023)
11.10.5 Sigma-Aldrich Corp Recent Development
11.11 Miltenyi Biotec
11.11.1 Miltenyi Biotec Company Detail
11.11.2 Miltenyi Biotec Business Overview
11.11.3 Miltenyi Biotec Cell Expansion Technologies Introduction
11.11.4 Miltenyi Biotec Revenue in Cell Expansion Technologies Business (2018-2023)
11.11.5 Miltenyi Biotec Recent Development
11.12 Life Technologies
11.12.1 Life Technologies Company Detail
11.12.2 Life Technologies Business Overview
11.12.3 Life Technologies Cell Expansion Technologies Introduction
11.12.4 Life Technologies Revenue in Cell Expansion Technologies Business (2018-2023)
11.12.5 Life Technologies Recent Development
11.13 Replicell
11.13.1 Replicell Company Detail
11.13.2 Replicell Business Overview
11.13.3 Replicell Cell Expansion Technologies Introduction
11.13.4 Replicell Revenue in Cell Expansion Technologies Business (2018-2023)
11.13.5 Replicell Recent Development
11.14 Neximmune
11.14.1 Neximmune Company Detail
11.14.2 Neximmune Business Overview
11.14.3 Neximmune Cell Expansion Technologies Introduction
11.14.4 Neximmune Revenue in Cell Expansion Technologies Business (2018-2023)
11.14.5 Neximmune Recent Development
11.15 TC Biopharm
11.15.1 TC Biopharm Company Detail
11.15.2 TC Biopharm Business Overview
11.15.3 TC Biopharm Cell Expansion Technologies Introduction
11.15.4 TC Biopharm Revenue in Cell Expansion Technologies Business (2018-2023)
11.15.5 TC Biopharm Recent Development
11.16 Pluristem Therapeutics
11.16.1 Pluristem Therapeutics Company Detail
11.16.2 Pluristem Therapeutics Business Overview
11.16.3 Pluristem Therapeutics Cell Expansion Technologies Introduction
11.16.4 Pluristem Therapeutics Revenue in Cell Expansion Technologies Business (2018-2023)
11.16.5 Pluristem Therapeutics Recent Development
11.17 ReNeuron
11.17.1 ReNeuron Company Detail
11.17.2 ReNeuron Business Overview
11.17.3 ReNeuron Cell Expansion Technologies Introduction
11.17.4 ReNeuron Revenue in Cell Expansion Technologies Business (2018-2023)
11.17.5 ReNeuron Recent Development
11.18 Voria Biomaterials
11.18.1 Voria Biomaterials Company Detail
11.18.2 Voria Biomaterials Business Overview
11.18.3 Voria Biomaterials Cell Expansion Technologies Introduction
11.18.4 Voria Biomaterials Revenue in Cell Expansion Technologies Business (2018-2023)
11.18.5 Voria Biomaterials Recent Development
11.19 CellProthera
11.19.1 CellProthera Company Detail
11.19.2 CellProthera Business Overview
11.19.3 CellProthera Cell Expansion Technologies Introduction
11.19.4 CellProthera Revenue in Cell Expansion Technologies Business (2018-2023)
11.19.5 CellProthera Recent Development
11.20 Cytomatrix
11.20.1 Cytomatrix Company Detail
11.20.2 Cytomatrix Business Overview
11.20.3 Cytomatrix Cell Expansion Technologies Introduction
11.20.4 Cytomatrix Revenue in Cell Expansion Technologies Business (2018-2023)
11.20.5 Cytomatrix Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Becton
Dickinson
GE Healthcare
Thermo Fisher Scientific Inc.
Corning Inc
Danaher Corp
Merck Millipore
Terumo BCT
STEMCELL Technologies
Sigma-Aldrich Corp
Miltenyi Biotec
Life Technologies
Replicell
Neximmune
TC Biopharm
Pluristem Therapeutics
ReNeuron
Voria Biomaterials
CellProthera
Cytomatrix

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.